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Objective: Investigating the effects of electro-acupuncture (EA) treatment on mice with
Alzheimer’s disease (AD), using Morris water maze (MWM) for spatial learning and
memory behavior tests combined with micro-positron emission tomography (micro-PET)
imaging for glucose metabolism in hippocampus.
Methods: Thirty seven-month-old APP/PS1 mice were randomly divided into AD Model
group (AD group), medicine group (M group) and EA group, C57BL/6 mice were used
for Normal control group (N group), n = 10 in each group. Mice in M group received
donepezil intervention by gavage with dose at 0.92 mg/kg. EA was applied at Baihui
(GV20) and Yintang (GV29) acupoints for 20 min then pricked at Shuigou (GV26)
acupoint, while mice in N, M and AD groups were received restriction for 20 min, with all
treatment administrated once a day for 15 consecutive days. After the treatment, MWM
was performed to observe behavioral changes in mice, then hippocampus glucose
metabolism level was tested by micro-PET imaging.
Results: Compared with that of AD group, the escape latency of M and EA groups
declined significantly (P < 0.01), while the proportion of the platform quadrant swimming
distance in total swimming distance showed an obvious increase (P < 0.01), and
EA group occupied a higher percentage than that in M group. The micro-PET
imaging showed that mice in AD group performed a lower glucose metabolic rate in
hippocampus compared with N group (P < 0.01). Both M and EA groups presented
a significant higher injected dose compared with AD group (P < 0.01), and the uptake
rate of EA group was higher than M group.
Conclusion: Both donepezil and EA have therapeutic effects on AD mice. To a certain
extent, EA shows a better efficacy in treatment of AD by improving the spatial learning
and memory ability, while also enhancing glucose metabolism in hippocampus.
Keywords: electro-acupuncture, Alzheimer’s disease, micro-PET, glucose metabolism, hippocampus
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INTRODUCTION
Alzheimer’s disease (AD), also called senile dementia, is a
common central nervous system (CNS) degenerative disease,
which is characterized by progressive memory impairments,
aphasia, agnosia, executive dysfunction, accompanied with
varying degrees of personality and behavior changes. With the
advent of global aging society, AD has becoming a serious threat
to humanity. Consequently, the prevention and treatment of
AD has become an urgent issue that needs earnest study and
solution.
Electro-acupuncture (EA), combining traditional
acupuncture with modern electrotherapy, is a promising
therapy that has been widely used in clinical practice, especially
exerting beneficial effects in CNS diseases such as depression,
spinal cord injury (SCI), stroke and AD (Guo et al., 2014; Mo
et al., 2014; Deng et al., 2016; Lai et al., 2016). The mechanism
of AD mainly lies in two aspects of deficiency in origin and
enrichment in symptom in accordance with the Traditional
Chinese Medicine (TCM) theory. Deficiency of essence and
debility of brain marrow were the basic pathogenesis of AD,
while stagnation of phlegm in brain collateral was reflected as an
excessive symptom in superficial. There exists some indivisible
relations between Governor Vessel (GV) and brain, both in
distribution and in function. Clinical and experimental studies
have shown that acupuncture at GV possessed therapeutic effects
in AD treatment (Yang et al., 2013; Jiang et al., 2015; Wang et al.,
2015).
Pathologically, AD is generally characterized by the synergy
between the extracellular accumulation of Aβ plaques
and presence of neurofibrillary tangles containing hyper-
phosphorylated tau, which activates microglia and astrocytes
then subsequent inflammatory reaction. A progressive damage
of synapse leads to neuronal apoptosis, which consequently
presents a glucose metabolism level decrease in specific regions
of the brain (Brun and Englund, 1986; Grundke-Iqbal et al.,
1986). Present studies on AD animal models and curative
effect evaluation are mainly based on behavioral observation,
neuro-biochemical and pathological tests. There is, however,
some valuable imaging methods like magnetic resonance
imaging (MRI), Position emission computed tomography (PET)
and multiple modality imaging which can reflect objective
and reliable brain structure and activity changes were often
neglected.
In this study, we selected 7-month old APP/PS1 double
transgenic mice as the AD animal model, and applied Morris
water maze (MWM) and non-invasive in vivo imaging micro-
positron emission tomography (micro-PET) to evaluate the
effect of EA treatment. We preferred the GV acupoints Baihui
(GV20), Yingtang (GV29) and Shuigou (GV26) as acupuncture
prescription. Escape latency and target distance proportion
were used to analyze spatial learning and memory ability, 18F-
fluorodeoxy glucose (18F-FDG) uptake rate in each gram of
hippocampus tissue presenting glucose metabolism levels. This
study aims to evaluate the curable effect of EA on AD model mice,
explore its mechanism and provide reliable experimental basis for
clinical treatment of AD as expected.
MATERIALS AND METHODS
Experimental Animals and Grouping
A total of 30, 7-month old, clean grade, male APPswe/PS1dE9
mice on a C57BL/6 background [B6/J-Tg (APPswe, PSEN1dE9)
85Dbo/Nju, ID: D000268, http://www.nbri-nju.com/strain-view-
D000268?search=APP&description=true&category_id=15]
were randomly divided into AD model group (AD group),
Medicine group (M group) and EA group, n = 10 in each
group, with 10 aged-matched littermate negative transgenic
mice served as normal control group (N group). All animals
were sourced from Model Animal Research Center of Nanjing
University [Certificate number: SCXK (SU) 2010-0001], with
weight ranging in (30 ± 2) g. Laboratory animal barrier system
is provided by Experimental Animal Centre of First Teaching
Hospital of Beijing University of Chinese Medicine. Housed
mice separately in single cages in a temperature-controlled
room (23 ± 1◦C), under 12-h light/dark cycle and (55 ± 5) %
humidity, in avoidance of outside interference and fed ad-libitum
on standard chow with open access to water. All experimental
procedures were in accordance with the Guidelines for the
Care and Use of Laboratory Animals of the Ministry of Science
and Technology of the People’s Republic of China, and the
Experimental Animal Research Ethics Committee of Beijing
University of Chinese Medicine approved the study protocol. We
made all efforts to minimize animal suffering and sacrifice in this
experiment process.
Reagents and Apparatus
Reagents and apparatus are displayed in Table 1.
Methods of Treatment
Mice in N group received no treatment, but were grabbed and
bound when mice in other groups were receiving treatments
to ensure an equivalent condition. Mice in AD group were
treated in accordance with N group. Donepezil hydrochloride
tablets were crushed and dissolved in distilled water, with the
dose at 0.92 mg/kg and delivered to mice by oral administration
in M group, which were grabbed and bound as N and AD
group.
Mice in EA group received EA treatment. The acupoints
Baihui (GV20), Yintang (GV29) and Shuigou (GV26) in GV
were chosen according to document (Li, 2007; Guo and Fang,
2012). Acupoints location in mouse were well-correspond to the
anatomical site of human acupoints, GV20 is at the midpoint
between the auricular apices, GV29 is located midway between
the medial ends of the two eyebrows, while GV26 is located below
the mouse nasal septum, at the junction of the lower two thirds
and upper one third of the cleft lip midline (Figure 1). Sterile
acupuncture needles were separately inserted with downward
horizontal at GV20 and upward horizontal at GV29, 0.5 cm in
depth. Then needles were connected to a programmed apparatus,
and stimulated with sparse waves (2 Hz in frequency, 2 V
in voltage, and 0.1 mA in electric current) generated from
EA apparatus, which would be the most preferable if slight
trembling of animal’s head was observed. Vertical pricking at
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TABLE 1 | Reagents and apparatus used in research.
Reagents and apparatus Source Details
Donepezil Hydrochloride
Tablets
eisai (China) Co., Ltd Certificate number: H20050978, specification: 5 mg per
pill × 10 pills
Disposable sterile acupuncture
needle
Beijing Zhongyan Taihe Medical Instrument, Co.,
Ltd
Model: ZYTH2013030504, specification:
0.25 mm × 13 mm
Electro-acupuncture (EA)
apparatus
Peking University Institute of Science Nerve and
Beijing Hua Wei Industrial Development Company
Model: HANS-LH202
18F-FDG tracer PET-CT Center, Cancer Hospital, Chinese Academy
of Medical Sciences, Peking Union Medical College
—
Inveon Micro PET/CT scanner Siemens Preclinical Solution USA, Inc., Knoxville,
TN, USA
Provided by the Institute of Laboratory Animal Science,
Chinese Academy of Medical Sciences and Comparative
Medical Center, Peking Union Medical College
Morris water maze Shanghai Xinruan Information Technology, Co., Ltd Model: XR-XM101
Software of image acquisition
and analyzing system
China Daheng Group, Inc. China Daheng Group, Inc., Beijing Image Vision Technology
Branch
FIGURE 1 | Mouse acupoints location we applied in this study.
GV26 acupoint was manipulated at the end of EA treatment. All
treatment approaches should be implemented for 20 min, once a
day for 15 consecutive days.
Morris Water Maze Test
Morris water maze (MWM) is a well-validated test for spatial
learning and memory. Over the course of test, the experiment
room should maintain a sound insulation, indirect light source
and low-light situation environment, with remaining objects in
this room at the original location and experimental conditions
should be unchanged. After previous treatments, mice were
tested in a circular water tank (90 cm in diameter and 50 cm in
depth), which was randomly divided into four equal quadrants (I,
II, III, IV) and set an escape platform (circular, 5 cm in diameter
and 28 cm in height) at the center of III quadrant. The tank was
filled with warm water (22 ± 2◦C) and made opaque by adding
0.5 kg skim milk powder to the depth of 30 cm. Visual cues
in different shapes were placed on tank wall of each quadrant,
in plain sight of the mice. All trials were tracked automatically
by a digital camera (set at 2 m ceiling straight above the water
tank center) and connected with image acquisition system. With
the aim to evaluate the changes of learning and memory ability,
each animal received a 5-day hidden platform trial then a 1-day
probe trial. In order to familiarize mice with the test environment,
experimental animal freely swam in the water tank (without
platform) for 90 s in the morning and afternoon separately on
the day before the hidden platform trial. Mice were placed the on
the platform for 10 s to observe the surrounding environment
first, and the hidden platform remained in a fixed location
throughout the trail. Then, we selected three entry points in I,
II, IV quadrant respectively, which should have equal distance
to the center of the tank, and experimenter gently placed the
animal into the water with its head toward the tank wall. We
recorded the escape latency (expressed by the swimming time
spent on finding submerged platform) and the swimming route
if animal found the hidden platform within 60 s and remained
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on it for 5 s. If animal could not find the platform in 60 s, it
would be removed from the water and placed on the platform
for 10 s to observe and memorize the location, then we recorded
60 s as its escape latency. The hidden platform trial repeated
for five consecutive days. For the probe trial, removed hidden
platform and placed mice in I, II, IV quadrant respectively,
recorded whole swimming route and time spent on III quadrant
within 60 s, to analyze their spatial memory and learning ability.
During the trials, all mice were placed back in their resident
cages using a spoon-net in order to avoid direct contact with the
experimenter.
Micro-PET Imaging
We randomly selected four mice from each group for the
micro-PET imaging. Previously, mice were fasting and water
deprivation for 6 h, the blood glucose levels were measured
in normal range (7.0–10.0 mmol/L). In this experiment, mice
were anesthetized with isoflurane (2% in 100% oxygen, 1 L/min)
inhalation. 14.8–16.5 MBq of 18F-FDG tracer was injected to
caudal vein when mice were fully anesthetized, micro-PET
scanning performed 50 min after the injection. The experiment
animal was placed in the prone position on the examination
bed, with isoflurane continuously carried by breath mask to
ensure animal remain completely unconscious throughout the
10 min scanning process, micro-PET captured single frame
image. Image reconstruction: micro-CT scans were performed
with an X-ray tube voltage of 80 kV, a current of 500 µA,
an exposure time of 200 ms, filtered back projection (FBP)
and CT photon attenuation correction were used for image
reconstruction (pixel size 0.2 mm × 0.2 mm × 0.8 mm),
micro-PET image frames were taken 30 s/frame. Regions of
interest (ROIs) selection: experimenter (who is blind to the
entire experiment process) manually selected three-dimensional
ROIs of hippocampus on PET/CT images, in transverse, coronal
and sagittal plane. The percentage of injected dose per gram
of hippocampus tissue (%ID/g) was determined on micro-PET
images. All images were traced by an investigator blinded to
experimental design.
Statistical Analysis
Statistical analysis was performed with software SPSS, version
17.0 (SPSS, Inc., Chicago, IL, USA), and data were expressed as
mean± standard deviation (x¯ ± s). Hidden platform trial results
were analyzed by repeated measures analysis of variance, while
data of probe trial and micro-PET imaging were analyzed by
single factor analysis of variance (one-way ANOVA), and LSD
pairwise comparison method was used among groups. P-values
less than 0.05 were considered statistically significant.
RESULTS
All mice were completed the Morris water maze test. Due to
factors of anesthesia situation, tail vein injection and tracer’s
metabolites, which may influence the scan results, we failed to get
the data of one mouse in M group during the micro-PET imaging
process. The data of this mouse were included in the analysis of
Morris water maze results but excluded from the micro-PET data
analysis due to its absence.
Morris Water Maze Test
In the hidden platform trial, the escape latency time in each
group showed a downward trend with the training time
extension (Figure 2). Compared with the N group, longer escape
latency time in AD group was observed (P < 0.01), suggesting
that 7-month APP/PS1 mice shown an obvious disability in
learning and memory. The escape latency time in the AD
group was significantly longer than that in the M and EA
groups (P < 0.01), and the escape latency time decreased more
remarkably in EA group than that of the M group (P < 0.01)
(Table 2).
FIGURE 2 | Trends of escape latency time of each group in hidden platform trial.
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TABLE 2 | Comparison of escape latency time of each group in hidden platform trial (x¯ ± s, s, n = 10).
Groups Cases Day 1 Day 2 Day 3 Day 4 Day 5
N 10 60.00 ± 0 58.07 ± 0.74 55.87 ± 1.01 53.07 ± 1.76 50.03 ± 3.98
AD 10 60.00 ± 0 59.80 ± 0.71 60.13 ± 0.73NN 59.80 ± 0.71NN 58.20 ± 3.22NN
M 10 60.08 ± 0.50 59.06 ± 0.58 58.39 ± 1.08N∗ 56.44 ± 0.91∗∗ 53.42 ± 2.55∗∗
EA 10 60.07 ± 0.46 58.95 ± 0.58NN 57.88 ± 0.80N∗∗ 55.43 ± 0.86N∗∗ 50.64 ± 2.21∗∗
NCompared with the N group, P < 0.05; NNCompared with the N group, P < 0.01; ∗Compared with the AD group, P < 0.05; ∗∗Compared with the AD group, P < 0.01.
After 5-day training trail, probe trial was used for testing the
maintenance of memory, while One-way ANOVA was performed
to determine the ratio of the swimming distance in platform
quadrant to the total swimming distance. A higher ratio of
swimming distance in the platform quadrant could be considered
as a higher level of memory retention. In this trial, we found that
the ratio of AD group was significantly lower than those in N
group (P < 0.01); both M and EA group showed a significant
higher ratio than AD group (P < 0.01); and EA group occupied
a higher percentage compared with the M group (Table 3;
Figure 3).
Micro-PET Imaging of Hippocampus
The ROIs of hippocampus for PET data analysis are outlined
in Figure 4. Standard color code (from Minimum = 0 to
Maximum = 10) was used to display the metabolic rate of
TABLE 3 | Ratio of the swimming distance in platform quadrant to the total
of each group in probe trial (x¯ ± s, %, n = 10).
Groups Cases Ratio
Normal Control Group (N) 10 0.26 ± 0.02
Model Group (AD) 10 0.17 ± 0.02
Medicine Group (M) 10 0.22 ± 0.02
EA Group (EA) 10 0.25 ± 0.02
glucose in mice hippocampus. The left of the observer presents
the left of the animal. After the treatment, mice in M and EA
groups showed an increased glucose metabolic rate than that in
AD group (Figure 5). Based on data obtained from micro-PET
scanning, we made further calculation and comparison of uptake
rate of 18F- FDG per gram in hippocampus among groups.
The results showed that the uptake rate in hippocampus of AD
group was significantly lower than that in N, M and EA groups
(P< 0.01). The uptake rate of EA group was higher than M group
(Table 4).
DISCUSSION
Traditional Chinese medicine holds the opinion that “GV
converged Yang channels” and “all Yang channels circulate in the
head and go into the brain,” which indicates that GV could govern
Yangqi over the body and closely related to brain functions.
Any dysfunction of the brain might induce a series of mental,
conscious and cognition diseases, such as AD. Based on the
conventional theory that “Diseases at the point where a channel
travels by can be treated by acupuncture on the channel.” In this
experiment, GV20, GV29 and GV26, located on the pathway of
the GV on the head, were selected for promoting the function of
GV. A wealth of researches support that acupuncture treatment
especially acupuncture at GV acupoints could have a positive
effect on AD (Li et al., 2014; Zhou et al., 2015).
FIGURE 3 | Comparison of ratio of the swimming distance in platform quadrant to the total of each group in probe trial. NCompared with the normal
control group, P < 0.01; ∗ Compared with the model group, P < 0.01.
Frontiers in Aging Neuroscience | www.frontiersin.org 5 January 2017 | Volume 9 | Article 5
fnagi-09-00005 January 24, 2017 Time: 13:45 # 6
Cao et al. Electro-acupuncture Increased APP/PS1 Mice’s Glucose Metabolism
FIGURE 4 | Regions of interest (ROIs) of hippocampus were shown in
red.
We chose APPswe/PS1dE9 double transgenic mouse as the
AD model. This specific transgenic mouse is harboring chimeric
mouse/human familial AD genes for β-amyloid precursor
protein (APPswe) and a mutant human presinilin 1-246E (PS1-
246E), which could propose a series of pathological changes of
AD and commonly accepted in pathogenesis and prevention
researches (Machová et al., 2008). One research found that
active microglia around Aβ plaque increased significantly in 7-
month-old APPswe/PS1dE9 mouse brain, while the level and
function of transport proteins decreased with the increase of
age (Chung et al., 2010). So far, some studies have shown
that APPswe/PS1dE9 double transgenic mice demonstrated
deficits in short-term memory, spatial memory loss and
cognitive impairment at approximately 7–8 months of age and
progressively throughout their lifespan (Gimbel et al., 2010;
Scullion et al., 2011).
Here, we administered donepezil as positive control.
Donepezil (Aricept) is an FDA-approved drug and the most
commonly used anticholinesterase inhibitor for AD in clinical
medication treatment, which has certain therapeutic effects in
enhancing hippocampal neurogenesis and improving cognitive
function. As an acetylcholinesterase inhibitor, donepezil extends
its effects on depletion of nicotinic acetylcholine receptors
and loss of cholinergic neurons. Due to its high selectivity,
reversibility and sustained drug effects, donepezil was used in
treat different stages of AD, from mild to severe. This effective
drug is not only enhancing neurogenesis, improving cognition,
learning and memory but preventing the aging progress.
A number of studies using animal models have showed that
donepezil possesses the neuroprotective activity in vivo and
in vitro (Ryan et al., 2001; Takada et al., 2003), and clinical trials
demonstrated that donepezil could considered as a safe and
effective drug (Rogers and Friedhoff, 1996; Rogers et al., 1998;
Bullock et al., 2005).
Alzheimer’s disease is characterized by an insidious onset and
inexorable progression of brain atrophy, and common symptoms
including gradual impaired memory, language obstacle,
deterioration of visuospatial skill, count disturbance, behavioral
FIGURE 5 | Glucose metabolic rate of Each Group in micro-PET imaging.
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TABLE 4 | Comparison of uptake rate of 18F- FDG per gram in
hippocampus of each group in micro-PET imaging (x¯ ± s, n = 4,4,3,4,
%ID/g).
Groups Cases %ID/g
Normal Control Group (N) 4 7.75 ± 0.39
Model Group (AD) 4 3.88 ± 0.60NN
Medicine Group (M) 3 5.13 ± 1.27NN
EA Group (EA) 4 6.35 ± 0.87N**
NCompared with the N group, P < 0.05; NNCompared with the N group, P < 0.01;
∗∗Compared with the AD group, P < 0.01.
and psychological abnormalities. So far, the criteria for clinical
evaluation and assessment of therapeutic effect for AD remain
unclear. At present, mini-mental state examination (MMSE) is
used in screening test for cognitive function evaluate worldwide,
but disadvantages such as low-sensitivity and influences by
age, geographic and educational levels cannot be ignored. As
advanced neural physiological activities, learning and memory
related to multiple encephalic regions, a variety of intracellular
signaling molecules and neurotransmitters are involved in such
complex processes. Hippocampus is an important structure
of brain’s limbic system and playing a crucial role in emotion,
behavior, learning, and memory (Lamberty and Gower, 1993).
In the 1960s, scientists studied memory and learning abilities on
experimental animals and discovered that hippocampus played a
vital role both in the short-term memory to long-term memory
transition and spatial information distinguish processes. Morris
primarily applied water maze device to detect the role of the
hippocampus in 1984, and found that hippocampal damage has
a serious negative impact on learning and memory function
(Morris, 1984). Previous research has shown that hippocampal
atrophy was known as an extremely sensitive and specific
indicator of early AD, appeared unexpected in the pathological
process (Jack et al., 1997). Rusinek proved that hippocampus was
the only structure involved in early onset process of AD (de Leon
et al., 1997). Imaging techniques such as MRI and PET have a
major role in improving our understanding of the biology of AD.
Laakso found that hippocampal atrophied significantly with its
volume decreased in AD patients via MRI (Laakso et al., 2000).
Recently, a meta-analyses research on the difference between
mild AD and non-AD, found that using a variety of biomarkers
and imaging examination in AD diagnosis, the sensitivity and
specificity of PET imaging are 90 and 89% respectively, and
non-AD subjects in control group showed 92% accuracy via
PET/CT scanning (Bloudek et al., 2011). Therefore, the PET/CT
may contribute to the differential diagnosis of AD.
Brain relies almost exclusively on glucose as its source of
energy, and the glucose level is considered as an indicator
of neuronal function. Many studies indicated that the
pathogenesis of AD is directly associated with glucose
metabolism disorders. Decreased intake of glucose, which
may act as a neurodegenerative component of AD, is the direct
substrate of cognitive impairment, and the rate of cognitive
decline is driven by the rate of neurodegeneration. Some research
suggests that metabolism diminution condition of brain existed
before cognitive decline onset (Hoyer, 2004), and neuronal
degeneration and loss could occur as a consequence of brain
atrophy and reduced glucose metabolism conversely in AD
patients (Nagren et al., 2010; Vallabhajosula, 2011; Braskie et al.,
2012). Brain metabolism can be measured via fluorine-18 labeled
fluorodeoxy glucose (18F-FDG) and PET imaging. To date,
18F-FDG is the most mature and widely accepted biomarker of
brain metabolism in the diagnosis and efficacious assessment of
AD. Studies proved that AD individuals showed gradually reduce
in cortex glucose metabolism, which was positively correlated
with the severity of AD symptoms (Politis et al., 2012; Dukart
et al., 2013). Possessed the features of non-invasion, measurable
and transferability from research to clinic, PET has emerged
as a reliable and applicable method for both basic medical
research and clinical practice in brain dysfunctions (Rowland
and Cherry, 2008). We used micro-PET in this study, which
has the 3R advantages (i.e., replacement of animals, reduction
in the number used and refinement of techniques that alleviate
potential pain and distress of the animals). CT images were
acquired just before each PET scan to provide an anatomic
reference for PET data.
In summary, the results of this study demonstrate that both
donepezil and EA stimulations have positive efficacy on AD
mice. EA shows better therapeutic effects on improving the
spatial learning and memory ability, while also enhancing of
glucose metabolism in hippocampus of APP/PS1 mice. Such
therapeutic mechanism might closely relate to EA stimulates
on GV, regulating qi and blood of the head, raising the lucid
Yang, restoring consciousness and inducing resuscitation. These
findings may indicate that EA could be a potential efficacious
therapeutic technique for treating AD, and this research also
serve as a stepping stone to future exploration in wide application
of acupuncture.
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